Emil Lou

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Emil Lou

Aug 14, 2024, 13:18 | Insight

Thejus Jayakrishnan: Multiomic analysis of early onset biliary tract cancer

Thejus Jayakrishnan, Hematology/Oncology Fellow at Cleveland Clinic, shared a post by Alok Khorana, Professor of Medicine at Cleveland…

Aug 9, 2024, 07:05 | Blog

Molecular differences in early-onset biliary tract cancer

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, posted on X about…

Aug 6, 2024, 11:09 | Insight

Emil Lou: ‘Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?’

Emil Lou, Associate Professor at University of Minnesota, shared a post on X: “‘Do tunneling…

Jul 24, 2024, 00:57 | Insight

Report on TROP2 expression across tumors

Stephen V Liu shared a paper by Dan Morgenstern-Kaplan et al, on X: "Report on…

Jul 13, 2024, 14:20 | Blog

Samuel Kareff: Pan-tumoral analysis of TROP2 among solid tumors

Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…

Jul 10, 2024, 07:25 | Blog

Emil Lou: Unraveling of cancer biomarkers

Emil Lou, Associate Professor at University of Minnesota, shared a post on X: ''Interdisciplinary collaboration…

Apr 28, 2024, 01:31 | Blog

Emil Lou: I can't wait to be part of this great lineup with Dr. G Curigliano and Patricia M. LoRusso at the Education Session

Emil Lou, Associate Professor at University of Minnesota, shared on X: “ADCs are a white-hot…

All: 7 Posts: 1 - 100